Presentation is loading. Please wait.

Presentation is loading. Please wait.

Keep control: Elite and post-treatment controllers

Similar presentations


Presentation on theme: "Keep control: Elite and post-treatment controllers"— Presentation transcript:

1

2 Keep control: Elite and post-treatment controllers
MOSY11 Track A. Symposia session Co-Chair: Guinevere Q. Lee PhD, Sarah Fidler MD PhD Share your thoughts on this presentation with #IAS2019

3 Definition: Elite Control
“Low/undetectable viral load and normal CD4 count in the absence of treatment” <1% of the population Progressors Viral load EC Limit of detection Time 714 definitions in 501 EC studies (Gurdasani AIDS 2014).

4 Definition: Post-treatment Control
“Sustained control of viremia after interruption of antiretroviral treatment” Antiretroviral treatment Non-PTC Viral load PTC Limit of detection Time

5 Mechanism(s) of control
HIV-specific CD8+ cytotoxic T cells Neutralizing antibodies ADCC: antibody-dependent cellular cytotoxicity NK cells HIV-specific CD4 cells Dendritic cells Intrinsic host factors / genotypes Intrinsic viral genotypes / integration sites Bodily compartments etc. Created via BioRender.com

6 Comparison between EC & PTC
Elite controllers (EC) Post-Treatment Controllers (PTC) HLA associated Very low HIV reservoirs Immune activation (low) Not HLA associated Low reservoirs Immune activation (low but can be variable)

7 Learning from EC and PTC…
Goals of HIV control: Maintain an undetectable viral load off ART: NO TRANSMISSION Normal immune function: NO CLINICAL RISK HIV sterilizing cure: Undetectable viral load, normal immune function Example: Berlin and London patients (2 cases) HIV remission or “Post-treatment Control”: Example: Mississippi baby, CHER, VISCONTI, very early ART (Asier and Deborah) How do elite controllers differ? (Hendrik and Xu)


Download ppt "Keep control: Elite and post-treatment controllers"

Similar presentations


Ads by Google